FDA Whistleblower Blasts New Merck Painkiller
The same U.S. Food and Drug Administrator that railed against the agency's actions during the rise and fall of Merck & Co. Inc.'s blockbuster arthritis drug Vioxx made headlines again on...To view the full article, register now.
Already a subscriber? Click here to view full article